Brief: Aurobindo Pharma Says Completion Of USFDA Inspection At Unit I Of Eugia Pharma Specialities
27/02/2026 10:43
Feb 27 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: COMPLETION OF US FDA INSPECTION AT UNIT I OF EUGIA PHARMA SPECIALITIES INSPECTION CONCLUDED WITH 4 OBSERVATIONS Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11